{"podcast":{"title":"Gynecologic Oncology Update","slug":"gynecologic-oncology-update-612940","podcast_index_feed_id":612940,"rss_url":"https://feeds.captivate.fm/gynecologic-oncology/","website_url":"https://www.researchtopractice.com/browse-tumor-types/ovarian-cancer","image_url":"https://artwork.captivate.fm/aa2bde68-0d40-4e41-b73e-fff33f9524cf/gou-podcast-logo-3000px.png","author":"Dr. Neil Love","episode_count":46,"summary":"This series bridges the gap between research and patient care by providing medical and gynecologic oncologists with access to the latest research developments and expert perspectives on up-to-date clinical management strategies for gynecologic cancers.","last_synced_at":"2026-07-21T08:21:50.117078+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940"},"episode":{"title":"For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress","slug":"for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress","published_at":"2026-07-06T20:20:00+00:00","page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress","show_page_url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940","url":"https://gynecologic-oncology.captivate.fm/episode/5899-ons2026-adc","audio_url":"https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/b976eebb-5924-4eaa-b0c6-9550965e9727.mp3","summary":"Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, including the following topics: Introduction (0:00) Overview of Antibody-Drug Conjugates (ADCs) (2:07) Current and Future Role of HER2-Targeted ADCs for Breast Cancer (6:23) Currently Available ADCs for Gynecologic Cancer Management (26:37) Currently Available ADCs for Lung Cancer Management (44:07) Current and Future Role of TROP2-Targeted ADCs for Metastatic Breast Cancer (56:55) Other ADCs That May Soon Reach the Clinic for Advanced Gynecologic Cancers (1:15:07) Promising Investigational Strategies Employing ADCs for Lung Cancer (1:25:01) NCPD information and select publications","meta_description":"Featuring perspectives from Ms Courtney Arn, Ms Jamie Carroll, Dr Edward B Garon, Dr Heather McArthur and Dr Kathleen N Moore, moderated by Dr Moore, incl…","key_points":[],"chapters":[],"topics":[],"duration_seconds":5334,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/gynecologic-oncology-update-612940/episodes/for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/gynecologic-oncology-update-612940/for-oncology-nurses-strategies-to-safely-and-effectively-implement-antibody-drug-conjugates-proceedings-from-the-2026-annual-ons-congress.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}